Federal Flashcards

Question

Treatment IND

Answer 1

For pt not enrolled but will likely die without it (no cure etc.) Must be in phase 2 or 3 trials

Answer 2

Priority review: for biologics applications or NDA, below three may also get priority. Reduces FDA review from 10 to 6 months Fast track: drugs for unmet clinical need Breakthrough: early clinical evidence of substantial benefit over existing drugs Accelerated approval: for drugs with long endpoints like OS. Can use other endpoints like DFS but need to validate results in post marketing

Answer 3

-Abbreviated NDA for generics -must show bioequivalence -first one to do this gets 6 months exclusivity

Answer 4

Supplemental NDA for after marketing changes to anything (dosage form, tablet strength, therapeutic use, etc.)

Answer 5

P: no other effective drugs in this area (get priority) S: similar to other drugs (standard review

Answer 6

Federally funded program providing 16 vaccines at no cost for children would wouldn’t get them due to cost

Answer 7

1234 (manufacturer)- 5678 (drug)-01 (package size

Answer 8

1234 (manufacturer)- 5678 (drug)-01 (package size) Not required to appear on bottles, labels, etc.

Answer 9

Every 2 years unless prior deficiencies

Answer 10

FDA sector that handles reports on bad or misleading advertising of drugs

Answer 11

Must say for prescription drugs but doesn’t need to say it when dispensing to customer (Otherwise misbranded)

Answer 12

-dispensing a drug without legal prescription or refills -quantity not listed -missing name or location of manufacturer -OTC package on the shelf whose package is damaged -not giving Medguide of PPI unless specifically directed to withhold by prescriber (if pt requests it then it must be provided even if prescriber directed otherwise) -if something on label is not prominently placed in a manner making it unlikely to be read -missing “warning- may be habit forming” when needed -if drug in USP and homeopathic pharmacopoeia must abide by USP reqs unless marketed as homeopathic -missing labeling or packaging about “deterioration” if applicable -dangerous to health when used in dose, frequency, duration recommended on the label -imitation if another drug -offered for sale under name Of another drug -legend drug sold w/o Rx -violations of REMS program Note: product insert is considered part of labeling Note: products do NOT require adequate directions for use if they are rx only to be dispensed by pharmacists, must have “caution federal law prohibits dispensing w/o Rx” simplified to “Rx only” In WA: -Can’t advertise that you compound drug for certain dx state -can’t repackage larger bottle into smaller w/o repackaged license

Answer 13

-name and address of manufacturer -drug name -net quantity -weight of active ingredient (e.g., 10 mg or 2 mg/mL) -“federal law prohibits…” or “Rx only” -route if not oral -special storage directions if applicable -lot # -exp date If not adhered to it’s misbranding

Answer 14

-yellow 5 (tartrazine) -aspartame -sulfites -mineral oil -wintergreen oil (methyl salicylate) -sodium phosphate -isoproterenol inh products -ipecac syrup -acetophenetidin -salicylates -alcohol warning

Answer 15

-corrects the problem of drug diversion from normal distribution channels -lots regarding shipping of drugs and stuff -retail pharmacies may NOT have samples -restricts resale of drugs by facilities -restrict importation Of drugs outside US -restrict distribution of samples -regulate wholesalers -required “pedigrees” (keep x3 yrs) -minimize presence of counterfeit drugs

Answer 16

-Retail pharmacies cannot have! -healthcare facility pharmacies can have IF prescribed requests them -prescribers can have if they provide written request

Answer 17

1 ounce (30 mL)

Answer 18

-OTC and Rx oral dosage forms -imprint identifies manufacturer and specific drug WA aligned with this. In WA manufacturers provide imprint info to commission who makes this available to pharmacies, ER, poison control May be exempt if imprinting is infeasible d/t size or texture, or if drug is prepared by the pharmacy itself

Answer 19

1. Professional label and package insert 2. MedGuide 3. Communication plan (how to communicate to providers that this drug is REMS drug!) 4. Elements to assure safe use -training of prescriber -training of dispenser -specify site of care -pt show evidence of safe use -pt agrees to be monitored -enrollment in registry 5. Implementation system- limits access and distribution of drugs with severe ADRs Assessments at 18 mo, 3 yr, 7yr

Answer 20

-thalidomide, isotretinoin, pioglitazone, alosetron, Bosentan, clozapine, dofetilide, alendronate, Butrans, Epogen, fentanyl buccal mucosal or nasal, hydro morphine ER, mifepristone, oxy CR

Answer 21

-generic and trade name (if appropriate) -quantity of active drug (and # of dosage units if >1) -name of manufacturer -lot number -expiration date State law also includes Rph or provider who packaged it

Answer 22

Unit dose: 25% of remaining time b/w repack date and manufacturer exp date OR 1 yr (whichever is less Multi-unit: manufacturer exp date or 1 yr whichever is less Note: not expiration date=misbranding!

Answer 23

-pharmaceutical companies but not individual hospitals -Doesn’t apply to samples -does apply to single unit containers in hospital distribution systems Bar code must contain NDC Okay I think barcodes need to be on: -prescription drugs -biologics -Rx and OTC drugs sold to hospitals Does not need to be on -rx drugs sold directly to pts from manufacturers -samples -IUDs -allergic extracts -medical gases -radiopharmaceuticals

Answer 24

-Customized or med packs that have several solid dosage forms with directions -requires same stuff as unit dose in addition to -serial # for med pack -rx serial # for each drug -exp is 60 days from when med pack was prepared

Answer 25

-reporting adverse events and product problems -voluntary for healthcare professionals (FDA form 3500) -mandatory for manufacturers, distributors, importers (FDA form 3500A)

Answer 26

Healthcare facilities are legally required to report suspected medical device related deaths to both FDA and manufacturers

Answer 27

FDA/CDC Vaccine Adverse Event Reporting System (VAERS) NOT medwatch FDAs center for veterinary medicine

Answer 28

-Manufacturer must send written recall notice to wholesalers and pharmacist for class I and II -pharmacies must be aware of recalls (for class I retailers notify the ***physicians*** of consumers) Levels most to least severe (wholesaler lvl—>retailer lvl—>consumer lvl)

Answer 29

-In WA you can NOT compound for resale! (You’re either a pharmacy of manufacturer) -Can have central location compound for HPACs -quantity reasonable for filling existing pt demand (estimated 30d supply) -not be sold to other pharmacies of physician offices -not available as commercial product -must use approved ingredients -can’t advertise specific drug products but can advertise that they specialize in compounding and ***can advertise that they compound for certain dx states*** -can’t make drugs that we’re withdrawn -interstate distribution of compounded drugs is no more than 5% of total Rxs filled -cannot compound copies of commercially available -reconstitution of fda approved product is not compounding -shouldn’t be compounding for office stock (considered manufacturing), this includes veterinary drugs You can’t compound certain DF if too difficult to make: dry powdered inhalers, metered dose inhalers, TDS,

Answer 30

-Non-aqueous solids: 6 month -aqueous oral solutions: 14 days fridge -aqueous topical: 30 days ——————————-/—/-/—————- Revised: -Non-preserved aqueous: 14 days ***in the fridge*** (all others are fridge or RT) -Preserved aqueous: 35 days -Non-aqueous oral ***LIQUIDS***- 90 days -Non-aqueous other forms- 180 days ***Aqueous is Aw>/=0.6 and non aqueous is <0.6***

Answer 31

No this is misleading and inaccurate, may be registered with FDA but doesn’t mean they’re inspecting it

Answer 32

On the back of the Rx or in a computer system

Answer 33

-the pharmacy does and should refuse to return it to the pt but can make a copy

Answer 34

10 years- actually I think the 10 years is for keeping a patient RECORD! I believe Rxs are usually just 2 years

Answer 35

-I think this might just be USP guidelines which are not part of WA regulations -Top of label: pt name, Rx #, drug (generic and brand), strength, directions -less critical info on bottom of label -large familiar font (TNR 12 or arias 11) -no acronyms -is “2” instead of “two” -avoid specifying exact times -should include indications for med -put label in pts language (drug name must also be in English) -label should have prescribers name -date

Answer 36

No federal law on this State law also has no specific requirement

Answer 37

-Rx drugs ***FOR ORAL DOSAGE FORMS!!!*** (even if an Rx for an OTC) -OTC ***controlled substances*** -most OTC do NOT require it- but ***must have at least one package size with CRC*** Follow non-Rx (OTC) -aspirin -NSAIDs (ibu >1g, nap >250 mg) -methyl salicylate -methacrylic acid -methyl alcohol -hydrocarbons, Sovents -methyl alcohol -iron ***>250 mg elemental pk*** -APAP ***>1gram*** (can have one marketed for arthritis w/o CRC) -Benadryl ***>66 mg/pk*** -loperamide -mouthwash (>3g ethanol) -lidocaine (>5 mg) -dibucaine (>0.5 mg) -fluoride ***>50 mg/pk*** -minoxidil (>14 mg) -liquid nicotine -ethylene glycol -H2SO4 -any non-Rx drug that used to be Rx (omeprazole, ranitidine, ***cetirizine, fexofenadine*** -Note: single dose packs may be ok depending on the specific amount allowed be drug -OTC with non safety cap should say “warning not for households with small children” -prescriber can request non-safety cap on a one time basis -pt can request non-safety cap on one time basis or ask for blanket waiver -request may be written or ***verbal*** but Rph should document who made the request in event of lawsuit -refill Rxs need new bottles and caps! (Can reuse bottle if it’s glass) -reversible caps are discouraged -don’t need child resistant when used inpatient in hospital -obviously for non oral dosage forms it’s not required (e.g., inhaler)

Answer 38

***all doses are per package!*** ***Note: steroids listed below are in dosepacks!*** -colesevelam <3.75 g -sevelamer <2.4 g -SL nitroglycerin -SL/chewable isosorbide 10 mg max -erythromycin ethylsuccinate granules <8g -erythromycin ethlysuccinate tabs 16g max -anhydrous cholestyramine powder -potassium in ***unit dose*** 50 meq/dose max -***sodium*** fluoride ***110 mg/pack max, <0.5%*** -betamethasone tabs in dispenser packs 12.6 mg max -mebendazole 600 mg max -Methylpred 84 mg max -colestipol 5 gram max -pancrelipase -birth control in memory packs -prednisone 105 mg max -conjugated estrogen 32 mg max -norethindrone 50 mg max -medroxyprogesterone acetate tabs -sacrosidase -hormone replacement therapy

Answer 39

-<20% of children can open (<5 yrs) can open in 10 mins ->90% of adults (50-70 yrs) can open in 5 mins, then open a second time within 1 min Note: it’s NOT child proof!!!

Answer 40

Many OTC and cosmetics must have tamper resistant packaging with indication on labeling explaining how to tell if it’s been tampered with Must be “tamper evident” Exemptions: -insulins -dentifrices -dermatological -lozenges

Answer 41

-must provide for certain drugs like Accutane, statins, or estrogen or progesterone products -applies to all physicians, community pharmacies, and hospital pharmacies!! -in hospital getting ***oral contraceptives,*** estrogen or progesterone hospital pharmacy must provide PPI before first dose then every 30 days (applies also to LTCF and nursing homes). Dispensed ***with every Rx*** in ambulatory setting -PPI must contain: highlights section, table of contents, benefits and risks of drug, date of approval, toll free # and Internet address -must give to it if they request ***(even if prescriber says not to give it)***

Answer 42

FDA requires them when: -pt labeling could prevent serious ADRs -high risk med relative to benefits -pt adherence to directions is crucial Med guides are -prepared by manufacturer -dispensed by pharmacist -may be required to be dispensed as part of REMS -should dispensed by anyone dispensing the med (even if it’s a practitioner rather than a pharmacy) Must give medguide when: -pt requests it ***(even if prescriber says not to give it)*** -each time med is dispensed to a patient in the outpatient setting -first time med is dispensed to provider for outpatient admin -when medguide is change -required by REMs -notice: not required in inpatient setting unless pt requests it or required by REMS (different from contraceptive PPI) Note: medguide is an advanced PIL basically and it will replace the PIL- ***don’t give out both!*** Classes: -anticonvulsants -antidepressants -anticoagulants -anti diabetic meds -NSAIDS -opioids -BZDs and Z drugs Advair, naproxen, interferon, Ritalin, amiodarone, warfarin, fentanyl, pimecrolimus, selegiline, epzicom, teriparatide, isotretinoin, mefloquine, lexapro, lindane, alosetron, mifepristone, tamoxifen, NSAIDs, hydromorphkne, tacrolimus, ribavirin, infliximab, Lenalidomide, serevent, acitretin, atomoxetine, pramlitide, Bosentan, trizivir, nevirapine, onalizumab, sodium oxybate, abacavir, bupropion

Answer 43

Pharmaceutical: same active ingredient, dose, dosage form, route, strength/conc (different excipient ok) Therapeutic: pharmaceutical equivalence and bioequivalence (same kinetics)

Answer 44

Same therapeutic moiety but different salts, esters, dosage forms, strength Can’t substitute these like you can generics

Answer 45

Product: generic interchange Therapeutic: therapeutic interchange based on policy at hospital and their formulary (one statin for another)

Answer 46

No, it’s the equivalent to writing for brand

Answer 47

-A rated (bio equivalent) -Can NOT interchange if B rated -can’t interchange to a different dosage form (e.g., ointment to a cream) -Must be same dose! -AA, AN, AO, AP, AT all interchangeable just different DF -AB mean prior issue have been resolved and are interchangeable -further divided by AB1, AB2, AB3: and number must match to be interchangeable (AB1 int w/ another AB1 product but NOT an AB2) -“RLD Yes” means it’s the reference product -amino acids for TPN can be interchanged freely as long as % AA is the same -certain drugs don’t have to be in orange book bc they’re grandfathered in -can also use USP/DI vol III, facts and comparisons, FDA website

Answer 48

90-110% Unless narrow therapeutic index then its 95-105% (digoxin, levothyroxine, phenytoin, warfarin, carbamazepine, lithium, cyclosporine, tacrolimus, theophylline, procainamide m, ethosuxamide

Answer 49

-Yes all CS can be mailed -inner container packaged and labeled correctly including name/address of pharmacy/dispenser -plain outer container

Answer 50

Upon filling rx Rph make/update or profile including: -name, address, phone # -age/dob, sex, dx info, allergies, prior meds, Rph comments -pt may refuse info-Rph to document and may refuse to fill Rx Review the following: -review meds for over or under utilization -check therapeutic duplication -incorrect doses or regimens -offer to counsel -must consider interactions w/OTC drugs and drugs filled at different pharmacy -must document observations concerning therapy/decisions in record -under WA: check for drug interactions and drug reactions as well -WA required examination of medication record EACH time rx is processed -Rph has duty to to take corrective action. Not required to contact MD in every case (may consult pt for “missing information”. Could use judgement to change DF in best interest of pt and tell MD later if not available)

Answer 51

-another req for federal funding of Medicaid programs -review of Rxs already dispensed -DUR Board may recommend that some prescribing habits of MDs change or recommend educational programs

Answer 52

-healthcare facilities must provide written privacy notice explaining how info will be used/disclosed and how they can get access to the info (“This notice dea revived how medical information about you may be used and disclosed and how you can get access to this information.”) -most require pt to sign an acknowledgement (signed form kept for 6 years after date sign or ***date of last fillled RX, whichever is later*** no req to resign again even after 6 years!! -“notice of privacy practice” given to each NEW pt at pharmacy (if pt refuses to sign can still serve them but must document they tried to get signature). One time thing and only one needed per chain. Friends/relatives can p/u rx but NOT sign this form -kids don’t need to sign, just the holder of the insurance -retain for 6 yrs -notice also posted in prominent location and on website -must provide notice if pt requests ***-Permission must be granted for even spouse to get info on medical records -telephone messages are ok to leave with relatives but can’t say the name of the drug or it’s use w/o pt permission*** -weird bc it’s ok for friends or family to p/u Rx w/o prior permission -note: hipaa does not confer a private right if action for individual patients ——————————————— -ok to use for TOP (consent not required) -must get consent for anything else including marketing and research (unless it’s de-identified)

Answer 53

Importation into US -importer must demonstrate that foreign made drug meets FDA reqs (only allowed if by a firm ***registered with the FDA***) and for approved drug Reimportation -drug shipped out of US then shipped back -only legal if performed by the original manufacturer

Answer 54

-Must display VIPPS seal (verified internet pharmacy practice sites) -must register with DEA 30 days prior to business involving CS -Monthly reports to DEA if dispensing at least 100 CS rx of 5000 CS dosage units -statement on homepage includes: compliant w/ Act, contact info (phone and email), pharmacy name and address, PIC info/degree/contact, licensed states, DEA registered, statement about requiring valid rx, certification that pharmacy is licensed to dispense CS, name/address/tele/degree of practitioners w/ contractual relationships to issue Rxs here

Answer 55

-unclear issue, seems may be ok, however NOT legal for CS

Answer 56

FDA is flexible on it if: -***Can NOT be for CS*** -intended use is unapproved and it’s for serious condition and effective tx isn’t available domestically -drug won’t be distributed to others -no unreasonable risk -individual confirms in writing drug is for own supply (max 3 mo) and give name/address of MD in US responsible for their tx or gives evidence that it’s for continuation of tx started in other country -drug can be shipped to pt, pharmacy, or MD FDA can still seize drug or refuse it’s entry

Answer 57

Every 3 years

Answer 58

-the registrant or POA -POA form must be signed by both people ***AND TWO witnesses*** and does NOT expire (could sign electronically) -person w/ POA ***does NOT have to be a pharmacist*** -file POA with executed DEA forms -POA does NOT get submitted to DEA -notice of revocation is also signed by two witnesses and the person revoking the POA

Answer 59

-warehouses for storing CS -MD office where drugs are prescribed but NOT dispensed or administered -common carriers (freight delivery companies for ex) -places where SALES are made but no drug is on site

Answer 60

-not more than 60 days prior to expiration -if bulk manufacturers or importers than not more than 120 days

Answer 61

-must list the schedule (can use C, e.g., “CII” -big enough to be seen w/o taking container off the shelf

Answer 62

-difenoxin (Lyspafeb) -bufotenine -diethylamide -methaqualone -heroin (diacetylmorphine) -LSD -marijuana -mescaline -peyote -***dextrorphan*** -3,4 dichloro…cyclohexyl… -prophetazine -methylhydromorphine -benzodioxol -butylone -pentylone -dimethoxy.. -cathinone

Answer 63

-tapentadol -Obetrol (an amphetamine) -biphetamine -glutethimide -cocaine -codeine ***only active ingredient, even if a syrup!! AND regardless of strength*** -if codeine is combo but ***>90 mg/dose*** -levomethadyl -meperidine -nabilone -dronabinol ***ORAL SOLUTION*** -tincture of opium -methamphetamine -pentobarbital -secobarbital -phencyclidine -phenmetrazine ***(Preludin)*** -THC if used for research -thiafentanil -coca leaves -ecgonine Precursor drugs: anthranilic acid, ephedrine, hydriotic acid, methylamine, phenyl acetic acid, pse, methephedrine, lead acetate, methyl formamide ***Note: pse and ephedrine non-controlled if sold in accordance with federal regs***

Answer 64

-***Note: codeine is still C2 as a combo if it’s above 90 mg/dose*** -thiopental (Pentothal) -perampanel (Fycompa) -APAP/codeine -anabolic steroids (“one”) -benzphetamine (Didrix, Inapentyl) -buprenorphine -butabarbital -butalbital (***Fiorinal NOT Fioricet***) -dronabinol (marinol) -nalorphine -phendimetrazine -ketamine -compound or mixture containing amobarbital, secobarbital, pentobarbital combined with a non-control drug -suppository of amobarbital, secobarbital, or pentobarbital -gamma-hydroxybutyrate -sodium oxybate -codeine <1.8 g/100mL or <90 mg/dosage unit -<300 mg dihydrocodeinone/100 mL or <15 mg/dosage unit -<1.8 g dihydrocodeine/ 100 mL or <90 mg/ dosage unit -<300 mg ethylmorphibe /100 mL or <15 mg/ dosage unit combined with non narcotic -<500 mg opium/100 mL or per 100g or <25 mg/dosage unit -<50 mg morphine/100 mL ***(2.5 mg/5mL)*** or per 100 g combined with non narcotic

Answer 65

-cathine (norpseudophed) -SPA -suvorexant -lorcaserin -eluxadoline -butorphanol -Chloral hydrate -clorazepate (Tranxene) -carisoprodol -chlordiazepoxide -diethylpropion -fenfluramine- ***DELETED!*** -mazindol -meprobamate -modafinil -pemoline -pentazocine -phenobarbital -phentermine -propoxyphene -sibutramine -tramadol -zaleplon -BZDs -alfaxalone -fospropofol

Answer 66

-APAP/codeine elixir -promethazine/codeine -diphenoxylate + atropine -ezogabine (Potiga) -lacosamide (vinpat) -pregabalin -brivaracetam (briviact) -Xcopri (cenobamate) -reyvow (Lasmiditan) -ganaxalone (Zytalmy) -Pyrovalerone -not more than 200 mg of codeine per 100 mL or g (<10 mg/dose) -not more than 100 mg ofdihydrcodeine per 100 mL or g -not more than 100 mL of ethylmorphine per 100 mL or g -not more than2.5 mg of diphenoxylate and not less than 25 mcg of atropine per dosage unit -not more than 100 mg opium per 100 mL or g - not more than 0.5 mg difenoxin and not less than 25 mcg atropine per dose unit

Answer 67

Phenobarbital products -isuprel elixir -Lufyllin-EPG elixir -Donnatal tabs and elixir -Anaspaz PB Butabarbital products -Pyridium plus -butibel Chlordiazepoxide (Librex caps) Just about all of these have been removed from the market Full list may be found at “exempt prescription products list” Still a CS and need Rx but exempt from registration, labeling, refill limits, and record keeping requirements of CS

Answer 68

When transferring from a central fill pharmacy to a retail pharmacy

Answer 69

-ordering C1 and C2s -issued in envelopes containing 7 or 14 forms (each in triplicate) -now single sheet forms provided in amounts based on need -order more with 222a (ordered by registrant or person w/ POA) -each has serial # -only one item per line -must note #of lines completed on bottom -name/address and dea# of supplier entered in form -sign and date -POA can be obtained and must be maintained for as long as for forms containing their name and must be available for inspection -POA can be revoked at any time by executing “notice of revocation” sign by person who authorized poa or successor -copy 3 (blue) kept by purchaser -copy 1 (brown) and 2 (green) supplier writes # of each item supplied and date shipped -supplier keeps copy 1 (brown) and sends copy 2 (green) to DEA -***now make paper or electronic copy for yourself and send original to supplier. Supplier keeps original and send report to DEA via ARCOS or send a copy of 222 to DEA end of month (or end of month in which final shipment made of partial or 60 day validity period ends)*** -can partially fill order and fill rest within 60 days (form is valid for 60 days from being filled out by supplier) -purchaser record on copy 3 the # packages received for each item and date received -supplier can endorse order to another if can’t fill it (must endorse entire order) write name and address of second supplier and signature on back of copy 1 and 2. Second supplier ship to purchaser -if purchaser wants to cancel part or all of order then notify supplier in writing and the ***supplier*** will draw a line through the item and write “cancelled” in the “shipped” column -max 10 items per form -if registration terminates unused order forms should be returned to DEA -purchaser document # of containers received and date received

Answer 70

-copy 3 (blue) kept by purchaser -copy 1 (brown) and 2 (green) supplier writes # of each item supplied and date shipped -supplier keeps copy 1 (brown) and sends copy 2 (green) to DEA at the end of the month

Answer 71

-must not fill order of form not done correctly or any alterations or erasure marks -Return copy 1 and 2 to purchaser with statement why -supplier can also not accept and order for any reason, and just sent a statement saying it’s not accepted. Purchased attach statement with all copies and retain in records

Answer 72

-fill out new form with statement that goods not received bc form lost -retain a copy of statement with copy 3 of new and old form and send a copy of statement to supplier with copy 1/2 -if supplier later received original they write “Not accepted” and return copies to purchaser who retains with copy 3 -must immediately report loss to DEA with serial # of form -if it’s supplier they must report at least date and name/address of purchaser -if entire book lost must report date of issuance -if found must immediately report to DEA Note: replace “copy x” with “copy” since triplicates aren’t a thing anymore

Answer 73

-etorphine, carfentanil, diprenorphine Must be stored in a safe or steel cabinet equivalent to US government class V security container

Answer 74

-can order CII-CV AND ***non-controls*** -no line item limit for a single order -faster and more accurate -decreased cost Other info: -must acquire digital certificate and private key for signatures for signing electronic orders. Public key must validate signature. Info to include on C1-2 order: -unique tracking # (last 2 digits of year, X, 6 characters, e.g., 25X123456) -DEA # -supplier name, address, DEA # -date order signed -drug name/strength or NDC, quantity in each pack and # of packs Supplier must: -verify integrity if signature and ensure digital certificate is not expired or on the revocation list -retain e-copy of order with # of containers supplier and date -can fill remainder of partial orders within 60 days (expires after that, same as 222) -***supplier cannot endorse order to another supplier (unlike 222)*** -supplier must send e-copy of order to DEA within ***2 business days*** -purchaser create record of quantities received and date and retain with e-copy -like with 222: if can’t be filled supplier send statement of such with reason why, or can refuse to accept for any reason and just need a statement saying so (purchaser link this stuff to original) -supplier may void full order: “void” on e-copy and send back (supplier does NOT need to retain copy but purchaser does), or part of order by indicating nothing shipped for each item voided -neither purchaser nor supplier may correct a defective order -lost order treated same as 222 except purchaser also send tracking # Purchaser and supplier must maintain records for 2 years

Answer 75

-You cannot compound a CS for sale directly to a physician (ie office use) w/o manufacturer license -aqueous, oleaginous, or solid DF -doesn’t contain more than 20% CS-***THIS IS NOT TRUE FOR WASHINGTON*** -only distributed to practitioner authorized to dispense

Answer 76

Yes And they can ***prepare*** it but the prescriber must sign it! (Unlike non-control where agent can sign it!!-actually idk about that) They can also call it in or fax it Prescriber can NOT delegate their signature!

Answer 77

Nope- he must order them from a supplier I.e, no rx for office use

Answer 78

No, must be a drug approved by FDA for that indication

Answer 79

AMA states “physicians should generally not treat themselves or members of their immediate family” and makes exceptions for emergencies (this is policy not law, federal law is not specific) So not a super clear answer Washington says no

Answer 80

-need third party auditor or approved certification body approve the program -identity proofing- ***two factor*** authentication (something you know, have (token), or are (biometric), or digital certificate -you can print a copy of an e-Rx but must be done only ***after*** it’s transmitted otherwise system should not allow it to be sent. Must say “copy only-not valid for dispensing” -Can NOT sign for mx patients with one signature but CAN sign mx RX for the same pt w/ one signature -signing and sending to pharmacy can be done separately -if it fails to send an intermediary can NOT fax it, must be printed by the prescriber and faxed (and say e-transmission failed), for C3-5 -must retain records electronically for 2 years -if also received at paper or oral rx for same script must write either that one or e-version void

Answer 81

-Pharmacy application service providers must back up files daily -e-rx must be stored electronically and paper rx via paper record -CS records kept x2 yrs

Answer 82

-***Prescribers agent CANNOT call it in, must be prescriber*** -quantity is limited to amount needed for emergency -immediately reduce to worrying -Rph makes effort to identify MD (c/b # etc.) -MD deliver hardcopy within 7 day (or postmarked within 7 days if mailed) or must call DEA -hardcopy says “authorization for emergency dispensing” and date of verbal order. Rph attach to verbal rx -central fill pharmacies not permitted to do this Emergency: -immediate administration is needed for proper Tx -no appropriate alternative -not reasonably possible to provide written rx in time

Answer 83

-can NOT be done bc pt requests- ***no longer true!!*** -MD or pt (not representative) can request partial over phone or in person, with remainder filled within ***30 days of date written!*** -document if request was from pt or MD -can be done if out of stock -write quantity on face of rx -fill remainder within 72 hrs or will need new rx after that (for OOS) -if pt doesn’t want or can’t pay for full quantity -if pharmacy attempting to confirm validity For terminally Ill or in nursing home/LTCF pt: -must confirm terminal illness and document on rx “terminally ill” or “LTFC” -on BACK of rx: date of partial, quantity, remaining quantity, Rph -fill remainder ***within 60 days*** C3-5: -partially filling ok if recorded like a refill -doesn’t exceed total quantity dispensed or 6 months _____________________________________ - OOS- remainder in 72 h or NOTIFY MD IF CANNOT; document quantity dispensed - 72 H OF PARTIAL FILL DATE ***Rph must have it ready in 72hrs but pt may p/u after 72hrs!*** - pt/MD request- remainder in 30d (no limit to amount of partial fills) - 30 D OF ISSUED DATE - LTCF OR ***terminal illness-*** remainder in 60 d - 60 D OF ISSUED DATE! -***RPH Must note on Rx if pt is LTCF or terminally ill***

Answer 84

-enter refills on ***back*** of rx or another readily retrievable document or ***electronically*** -following info retrievable: -drug name and dose -date filled or refilled -quantity -Rph initials -total # refills -if Rph initials and dates back of rx it’s assumes full quantity was refilled -pharmacy must have downtime procedure if normally done electronically

Answer 85

-Rph must verify and sign print out of each days CS refill data (signed by each Rph involved) -print out should be available to pharmacy within 72 hours from date of refill -alternative could use bound log book in which Rph signs statement each day attesting to refill data -either option must be kept for 2 years -sign at end of each shift Note: a central record keeping location must be capable of sending print out to pharmacy within ***48 hours*** Note: pharmacist manual only mentions CIII-IV in this section (not sure why 5 isn’t listed

Answer 86

-ultimate user is institutionalized AND -not more than 34 day supply or 100 units (whichever is less) dispensed -med is not in possession of the ultimate user -proper safeguards and records -system is adequate to identify the supplier, product, patient, directions, and cautionary statements

Answer 87

-one time basis unless shared real time database -communicated b/w Rph (or intern) ***Sending pharmacy*** -“VOID” on rx or indicate transfer for electronic rx -on BACK record: -name and address of pharmacy -DEA # of pharmacy -pharmacist receiving -also record date and name of sending Rph ***Receiving pharmacy*** -“Transfer” on face -record: -original date -date first dispensed -original refills -remaining refills -dates/locations of prior refills -pharmacy name, address, DEA or transferring pharmacy AND ***of pharmacy that originally filled it*** -Rx number (and original Rx # if different) -transferring Rph name -also need: date last dispensed, and name of transferring Rph -create record w/ receiving Rph name ***Note: this info is in addition to all prescription data***

Answer 88

-must be done by Rph ***(intern can do in WA)*** -240 mL (8 oz) or 48 dose units max for opium containing products (per 48 hours) -120 mL (4oz) max or 24 dose units for any other products (codeine) per 48 hours) -age 18+ -ID -record book including: -name and address -name and quantity of drug -date -Rph -maintain record book for at least 2 yrs -central fill pharmacy not included Washington aligns with this!

Answer 89

Retail sending it must: -write “Central fill” on Rx along with name, address, and DEA of central fill pharmacy -write name of ***retail Rph*** -write date -indicate ***refills dispensed and remaining*** -keep original rx for 2 yrs from date of last fill -record receipt of filled rx, delivery method, and person receiving Central fill pharmacy must: -keep copy of rx (fax or electronic record of ***pharmacy name, address, dea)*** -record date or receipt of rx and name of ***Rph filling it*** -record date of filling and of delivery and delivery method -include on label unique identifier indicating filled at central pharmacy Note: “CENTRAL FILL” is to be written on rx by retail NOT the central fill pharmacy

Answer 90

-reverse distributor fills out 222 for transfer then 41 sent to dea for actual destruction of CS -222 only used for c2

Answer 91

-may transfer up to 5% of total ***CS*** dosage units dispensed in ***a calendar yr*** otherwise need to register as a distributer (unless it’s bc it’s going out of business) -222 must be used if C1 or C2 -other CS document: drug name, strength, DF, quantity, date and name, address, and DEA # of each party -Note: in this case you CAN transfer the CS to MD office for purpose of general dispensing (bc this is not a prescription)

Answer 92

-222 used for c1 and c2 -other CS document: drug name, strength, DF, quantity, date and name, address, and DEA # of each party -***transferring pharmacy*** do complete inventory (also serves as initial inventory for receiving pharmacy), don’t need to send to DEA but new pharmacy must maintain all records for 2 yrs

Answer 93

Must keep records for: -drugs dispensed -CS ***administered*** for detox or maintenance Do NOT need to keep records for: -CS administered (other than above) -CS prescribed Note: -***NPs may dispense up to 72hr supply of CS***

Answer 94

-keep inventory records for 2 yr -C2 separate and C3-5 separate or readily retrievable -can use recording device but must promptly transcribe -include ALL CS (including not yet picked up rx, in warehouse, etc.) -financial and shipping records can be stored offsite at central location if DEA is notified starting ***14 days*** after notification unless denied (no permit needed), also allowed for records for remote dispensing devices at LTCF but not allowed for executed 222s, prescriptions, or inventories*** -Inventory must be dont upon opening or closing for the day and must be indicated on the inventory -Initial inventory done one first day of business or when issued a DEA registration (***even if it’s zero***) and then at least ***every 2 years*** (don’t need to send to DEA) -also inventory a drug if it becomes CS or changes schedules -exact counts for unopened bottles -exact counts for C1 or C2 -exact counts for any CS bottle holding >1000 tabs -estimate counts for C3-5 (<1000 tabs) -Not required by law, but recommended to record signature of people conducting the inventory -also inventory damaged/defective/impure substances and include reason for being maintained and if it’s capable Of being used to manufacture CS in finished for

Answer 95

-can’t employ someone with felony hx w/ CS or had DEA registration denied/revoked -could get waiver from DEA with lots of strict reqs and details including last offense, current activities, proposed access to CS, safeguards etc.

Answer 96

-Immediately ***upon discovery*** report ***directly*** to DEA -any “significant” loss (err on side of caution) -complete form 106- send original and a copy to DEA and keep another copy -should contact local police -if discovered that there’s no loss or theft the don’t need to submit form 106 and can notify DEA of this ***in writing*** -break/spillage is not “loss” so use for 41 instead Note: if shipment never reaches pharmacy the supplier is responsible, if Rph signs for it they are responsible Note: for central fill, the pharmacy (retail vs central fill) that is the one to contract with the common or contract carrier is the one who is responsible for reporting loss via form 106! DEA manual says report within one business day, so idk what is right- Both textbooks say immediately upon Discovery so maybe go with that Keep copy of 106 for 2 yrs

Answer 97

If unrecoverable: -Form 41 should be used to record it, 2 witnesses sign If recoverable, 3 options: -destroy it on-site -send to reverse distributor -contact DEA Diversion field office to request disposal assistance Do NOT just forward drug to the DEA!

Answer 98

->$500 (even if just attempted) -person killed or significant injury -interstate or foreign commerce is involved

Answer 99

-attorney general permits re-exportation of c1-4 to other countries if being shipped to DEA permit/license holder and DEA notified within 30 days

Answer 100

-3.6 grams per day -9 grams per ***30 day period*** -solid forms must be in blister packs with max 2 doses per blister pk -mail order max 7.5 g per 30 days -must be behind counter (front counter ok too) or locked in display case -don’t need a pharmacy to sell PSE -log book: name, address, date/time, signature (verified against gov ID), name of product and quantity, “notice false statement subject to criminal penalty” (federal), ***DOB and Type of ID*** (state law) -don’t need logbook if single sales of no more than 60 mg PSE (this is federal rule) -hold logbook entry for 2 yr -retailer must submit ***annual*** self certification to ***attorney general*** that staff are trained and above rules being followed Note: non-Rx phenylpropanolamine is not available on US or Canada Note: These reqs are for Non-prescription sales

Answer 101

-no prescribing for addiction(duh) -initial dose must not exceed 30 mg -total dose for day 1 must not exceed 40 mg unless MD documents that 40 mg wasn’t enough -prescriber can administer methadone to relieve acute withdrawal symptoms while arranging for tx program (max one day at a time, max 3 days) -Hospital may also give methadone to prevent withdrawal ***but withdrawal/methadone use CANNOT be the only reason that they are at the hospital*** (would need tx clinic for this) Take home limits: -pt can take home single dose for days when clinic is closed -day 0-90: 1 dose per week -day 91-180: 2 doses per week -day 181-270: 3 doses per week -day 271-365: 6 doses per week -after 1 yr: 2 week supply max -after 2 yr: one month supply but must make monthly visits

Answer 102

-active ingredient (including amounts) -inactive ingredients -uses -purpose (basically drug class “antihistamine”) -warnings -directions -other info If any above info is missing it’s misbranded Will generally also have: -exp date, lot, name and address of manufacturer, net quantity, what to do if overdose Also needs “DRUG FACTS”: 7 point label: -name -name and address if manufacturer, packager, distributor -net contents -active ingredients and quantity of certain other ingredients -name of any habit forming drug -cautions and warnings -directions for use

Answer 103

-FDA adverse event reporting system -receives reports form medwatch -reporting is voluntary for healthcare professionals but mandatory for manufacturers -used by CDER and CBER to monitor safety of products

Answer 104

-“pregnant or nursing seek advice from MD” -“especially important not to use in last 3 months of pregnancy” (for some drugs including aspirin) -list sodium content if >5 mg per dose and if daily dose is >140 mg must say “ask MD if on sodium restricted diet” (Can be “sodium free” if <5 mg, or “very low sodium” if <35 mg, or “low sodium” if <140 mg) -label indicate if: -calcium 20+ mg/dose -magnesium 8+ mg/dose -potassium 5+ mg/ dose -label warning for pts with electrolyte restricted diet if -sodium: 140+ mg/ day -calcium: 3.2 grams/ day -magnesium: 600 mg/ day -potassium: 975 mg/day

Answer 105

-full NDA -supplemental NDA -FDA may grant exception -Nonprescription drug advisory committee may recommend (would categorize it as category 1 (generally recognized as safe and effective “GRASE”) -category 2 (NOT generally considered safe/effective) -category 3 (insufficient data to permit classification) -Notice 2 is worse than 3!

Answer 106

None I don’t think, so if no refill instructions are written can refill as many times unless state has restriction on time or refills (so double check on state law for this)

Answer 107

-aerosol products -non-rx products not accessible to general public (used in hospitals) -lozenges and drugs in first aid kits -1 piece hard gelatin caps.. -insulins -dentifrices -dermatological -lozenges

Answer 108

-for health foods, food supplements, herbals, amino acids, vitamins, minerals -don’t need to prove efficacy (FDA can challenge and prove not effective) -just reasonable assurance that there’s no unreasonable risk -still has GMP guidelines but manufacturer runs its own tests -manufacturer keep records for 1 yr past exp or 2 yrs after distribution -company providing dietary ingredient doesn’t need to follow GMP unless directly packaging and selling that ingredient, manufacturer of supplement must ensure quality -need to be careful with the claims they make. Can speak in general terms but can claim to cure a dx! -sellers also can’t make these claims, they can’t put selective materials/books/articles with the product (must be entire book along with other materials and not place it with product), can add stickers or shelf talkers to product -ephedrine is banned from dietary supplements!

Answer 109

“These claims not evaluated by FDA. This product is not intended to diagnose, tx, cure, or prevent any dx”

Answer 110

Banned from ***dietary supplements***, ban doesn’t apply to RX, non-rx drug products, conventional foods like herbal teas, or traditional Chinese medicine

Answer 111

-listed in homeopathic pharmacopoeia of United States -must meet usual labeling requirements -English name is required (not just Latin) -I’d also listed in USP/NF must meet these stricter requirements -must use GMP -so not need expiration date -need to be very careful with claims of efficacy, should have disclaimer that there’s no good evidence and this should be clear to the consumer

Answer 112

-don’t have to meet GMP but needs to be sanitary (but will need to in the coming years!) -facilities must now be registered with FDA- renew every 2 yrs -don’t specifically have to be tested for safety, but if safety hazard they are considered misbranded ***(needs adequate substantiation of safety)*** -cosmetic facilities to report serious events to FDA within 15 days -label should have # to report ADRs -standardized testing for asbestos in talc containing products -animal testing for safety to be phased out -labels must list ingredients in descending order of predominance (often “water” is first) -coloring agents must be excepted for use or it’s adulterated -ingredients must be in USP/NF or CTFA (cosmetic ingredient dictionary) -perfumes and flavoring oils can be listed by name (rather than ingredient) -many need to be in tamper resistant packaging (vaginal or mouthwash) Sunscreen innovation act of 2014 goal is to speed approval of new sunscreen ingredients by FDA in

Answer 113

For pharmacy to buy 95% ethanol for compounding

Answer 114

-Purchase of tax free alcohol -Use is for medicinal or scientific use in or tx -may not be sold or loaned to other pharmacies or md office -may not be sold to outpatients -need running inventory -stored in locked fire resistant store room

Answer 115

-covers business employing 15+ -protects alcoholics but not drug addicts -protects HIV +, mental retardation, paralysis, epilepsy

Answer 116

Must inform employer within 5 days if convicted of criminal possession of drugs

Answer 117

-Residents drug therapy must be free from unnecessary drugs -limit use of psychotropic drugs -facility must employ Rph or consultant Rph -each residents drug regimen must be reviewed every ***30 days***

Answer 118

-reinstate 503a -establish outsourcing facilities (exempt from NDA and labeling reqs, but subject to GMP) -establish 10 year timeline for track and trace drug supply chain security -3 pieces of documentation for lawful distribution of drug-pharmacy don’t accept drug unless these are provided: -transaction hx -transaction information -transaction statement -sometimes won’t need these things if returning to wholesaler or delivering to pt of for emergency sales to md or pharmacy -pharmacy maintain above info for ***6 years*** -must notify secretary of illigitimate producrs within 24 hours via form 3911 -pharmacy can inly purchase barcodes serialized products -must participate in fully electronic traceability system In response to NE meningitis

Answer 119

***Note: reporting requirements apply to and pharmacy with internet modification regardless of whether any CS dispensed by pharmacy that month*** Internet pharmacies -no dispensing CS unless at least one in Persian physical exam in last 24 months -register with DEA if CS involved (“modification” of DEA registration)- no fee to apply -Must notify DEA and state board of pharmacy ***30 days prior*** to offer CS sale (completing app for modification of registration for online pharmacies satisfies “notification” for DEA, but need separate notification for state board) -must be registered as a pharmacy in EVERY state you intend to delivery CS to -must notify DEA ***30 days in advance*** of changing internet web address -Must submit ***monthly*** report to DEA of ***EACH CS*** if dispense 100+ RXs or 5000+ dosage units of ***TOTAL*** CS even if not all dispensed online!! ***if less than this still need to report a negative response!*** -report is due on the ***15th day*** of the following month Note: internet pharmacy can mean many things but essentially it must be in some way facilitating the delivery of CS to someone in the United States (eg. Advertisement alone is not internet pharmacy) Muse declare on homepage: “In accordance w/ CS act and DEA regs this online pharmacy has made the notifications to the dea administrator required by …” Must list all that other stuff on VIPS notecard including states internet pharmacy is authorized to dispense to Note: pharmacies EXEMPT if only filling “new” or “refills” for ***C3-5*** when pharmacy has already filled original Rx for that CS by non-internet means!

Answer 120

-pharmacy needs rx outsourcing doesn’t -outsourcing needs to follow GMP not pharmacies -outsourcing facility cannot wholesale -outsourcing facility must be registered with FDA not pharmacies WA does NOT recognize 503a and 503b! In WA if you’re doing non-or specific stuff you need a manufacturers license!

Answer 121

-name of preparation -active components -strength/ concentration -volume -route -internal ID # -BUD -initials of compounder -storage requirements -handling reqs -indication -name/address and contact info of compounding facility if not within the facility DF required for 795

Answer 122

No, not anymore

Answer 123

At time of DEA registration renewal demonstrate completion of relevant training (at least 8hrs for non-physicians) FYI: can’t use pain products (mono product, sublicaide, etc) for maintenance since this is diversion! (You CAN give combo product for pain!) Give with medguide

Answer 124

-privacy rule for narcotic tx programs -distinct from HIPAA -unlike hipaa, cannot disclose info to other providers UNLESS written consent has been provided Treatment programs may now include in their agreements with patients the right to disclose information to other tx providers (like pharmacies)

Answer 125

-Legalized cultivation and interstate transfer of hemp (must be <0.3% THC) -CBD like from hemp is legal but from marijuana is CS -now non-controlled but used to be c5 (used for seizures)

Answer 126

The patient or member of patients household! Exemption: can deliver CS in accordance w/ an RX for the purpose of prescriber administering it if it’s for maintenance or detox and an injection or implant -this is not providing stock for general dispensing -must be administered within ***14 days of receipt*** of the med

Answer 127

More permanent than a recall

Answer 128

-if only active ingredient it’s a C2 ***regardless*** of DF or strength -if >90 mg even if it’s in a combo it’s a C2 -if combo between 11 and 90 mg per dose it’s C3 -if combo and 10 mg or less it’s C5